Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure
- PMID: 22248521
- DOI: 10.1016/j.juro.2011.10.157
Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure
Abstract
Purpose: In this study we assessed bladder cancer health care and mortality trends in recent decades in a well studied arsenic exposed area in Northern Chile.
Materials and methods: Arsenic levels in the affected region were obtained for the last 60 years, and correlated with bladder cancer hospital discharge and mortality rates in recent decades.
Results: Bladder cancer hospital discharge rates were significantly higher in the affected region (peak RR 3.6, 95% CI 3.0-4.7). Mortality rates for bladder cancer showed a trend of increase during the period analyzed, reaching peak mortality rates of 28.4 per 100,000 for men and 18.7 per 100,000 for women in the last 10 years. Poisson regression models showed an increased mortality risk in the studied region compared to the rest of the country until the present for men (IRR 5.3, 95% CI 4.8-5.8) and women (IRR 7.8, 95% CI 7.0-8.7). Mean age at cancer specific death was significantly lower in the exposed region (69.6 years, 95% CI 68.4-70.7 vs 73.7 years, 95% CI 73.3-74.2, p <0.01).
Conclusions: Exposure to arsenic is related to a significant need for bladder cancer health care and to high mortality rates even 20 years after having controlled arsenic levels in drinking water. Affected individuals should be aware of the significant impact of this ecological factor. Further research is required to identify strategies for the management of bladder cancer in arsenic exposed populations.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.J Natl Cancer Inst. 2007 Jun 20;99(12):920-8. doi: 10.1093/jnci/djm004. Epub 2007 Jun 12. J Natl Cancer Inst. 2007. PMID: 17565158
-
Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000.Am J Epidemiol. 2007 Dec 15;166(12):1381-91. doi: 10.1093/aje/kwm238. Epub 2007 Sep 17. Am J Epidemiol. 2007. PMID: 17875584
-
Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.Environ Res. 2005 May;98(1):127-32. doi: 10.1016/j.envres.2004.07.013. Environ Res. 2005. PMID: 15721893
-
Does arsenic exposure increase the risk for liver cancer?J Toxicol Environ Health A. 2004 Oct 8;67(19):1491-500. doi: 10.1080/15287390490486806. J Toxicol Environ Health A. 2004. PMID: 15371225 Review.
-
Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.Regul Toxicol Pharmacol. 2008 Dec;52(3):299-310. doi: 10.1016/j.yrtph.2008.08.010. Epub 2008 Aug 26. Regul Toxicol Pharmacol. 2008. PMID: 18783726 Review.
Cited by
-
Bladder cancer in 2012: Challenging current paradigms.Nat Rev Urol. 2013 Feb;10(2):67-8. doi: 10.1038/nrurol.2012.252. Epub 2013 Jan 8. Nat Rev Urol. 2013. PMID: 23295237 Review. No abstract available.
-
Arsenic activates STAT3 signaling during the transformation of the human bronchial epithelial cells.Toxicol Appl Pharmacol. 2022 Feb 1;436:115884. doi: 10.1016/j.taap.2022.115884. Epub 2022 Jan 11. Toxicol Appl Pharmacol. 2022. PMID: 35031324 Free PMC article.
-
Promotion of arsenic phytoextraction efficiency in the fern Pteris vittata by the inoculation of As-resistant bacteria: a soil bioremediation perspective.Front Plant Sci. 2015 Feb 18;6:80. doi: 10.3389/fpls.2015.00080. eCollection 2015. Front Plant Sci. 2015. PMID: 25741356 Free PMC article.
-
Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs.BMC Res Notes. 2012 Apr 30;5:207. doi: 10.1186/1756-0500-5-207. BMC Res Notes. 2012. PMID: 22546077 Free PMC article.
-
Comparative Analysis of Very Reduced vs Full Dose BCG Treatment for High-Risk Non-Muscle Invasive Bladder Cancer: A Contemporary Experience from Chile.Bladder Cancer. 2023 Dec 13;9(4):327-334. doi: 10.3233/BLC-230047. eCollection 2023. Bladder Cancer. 2023. PMID: 38994240 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical